ES2108832T3 - Agente que mejora la circulacion periferica. - Google Patents

Agente que mejora la circulacion periferica.

Info

Publication number
ES2108832T3
ES2108832T3 ES93308301T ES93308301T ES2108832T3 ES 2108832 T3 ES2108832 T3 ES 2108832T3 ES 93308301 T ES93308301 T ES 93308301T ES 93308301 T ES93308301 T ES 93308301T ES 2108832 T3 ES2108832 T3 ES 2108832T3
Authority
ES
Spain
Prior art keywords
group
hydrogen atom
agent
peripheral circulation
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93308301T
Other languages
English (en)
Inventor
Sakae Murata
Hiroshi Narita
Minako Kaburaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Application granted granted Critical
Publication of ES2108832T3 publication Critical patent/ES2108832T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Processing Of Meat And Fish (AREA)
  • External Artificial Organs (AREA)
  • Confectionery (AREA)
  • Separation, Recovery Or Treatment Of Waste Materials Containing Plastics (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Vehicle Body Suspensions (AREA)

Abstract

SE PRESENTA UN DERIVADO DE (-)-CIS-1,5-BENZOTIACEPINA REPRESENTADA POR LA FORMULA O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE ESTE: DONDE R1 REPRESENTA UN GRUPO ALQUILO INFERIOR O UN GRUPO ALCOXI INFERIOR; R2 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALCANOILO INFERIOR; R3 REPRESENTA UN GRUPO ALQUILO INFERIOR; R4 REPRESENTA UN ATOMO HIDROGENO O UN GRUPO ALQUILO INFERIOR; R5 REPRESENTA UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO INFERIOR O UN GRUPO HIDROXIALQUILO INFERIOR ; Y A REPRESENTA UN GRUPO ALQUILENO INFERIOR, QUE ES UN AGENTE DE CURACION Y/O PROFILACTICO DE OBSTRUCCION ARTERIAL CRONICA, ENFERMEDAD DE RAYNAUD, ENFERMEDAD DE BU14EGERS, Y SIMILARES.
ES93308301T 1992-10-23 1993-10-19 Agente que mejora la circulacion periferica. Expired - Lifetime ES2108832T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28483492 1992-10-23

Publications (1)

Publication Number Publication Date
ES2108832T3 true ES2108832T3 (es) 1998-01-01

Family

ID=17683621

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93308301T Expired - Lifetime ES2108832T3 (es) 1992-10-23 1993-10-19 Agente que mejora la circulacion periferica.

Country Status (10)

Country Link
EP (1) EP0595526B1 (es)
KR (1) KR100194825B1 (es)
AT (1) ATE157874T1 (es)
CA (1) CA2108871A1 (es)
DE (1) DE69313775T2 (es)
DK (1) DK0595526T3 (es)
ES (1) ES2108832T3 (es)
GR (1) GR3024700T3 (es)
SG (1) SG48753A1 (es)
TW (1) TW273511B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101640897B1 (ko) 2015-09-16 2016-07-29 주식회사 지에이치비 주낙통 접합기 및 주낙통 접합방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
US4594342A (en) * 1984-04-10 1986-06-10 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivative
FR2623714B1 (fr) * 1987-11-26 1990-04-20 Ethypharm Sa Forme a liberation prolongee du diltiazem, et son medicament ainsi obtenu
JPH01186875A (ja) * 1988-01-19 1989-07-26 Tanabe Seiyaku Co Ltd ベンゾチアゼピン誘導体の製法
CA2049655C (en) * 1990-09-17 1996-11-12 Akio Odawara Pharmaceutical composition for inhibiting platelet aggregation
JP2712144B2 (ja) * 1992-02-06 1998-02-10 田辺製薬株式会社 血小板凝集抑制組成物

Also Published As

Publication number Publication date
KR100194825B1 (ko) 1999-06-15
GR3024700T3 (en) 1997-12-31
KR940008684A (ko) 1994-05-16
TW273511B (es) 1996-04-01
DK0595526T3 (da) 1997-10-13
DE69313775D1 (de) 1997-10-16
EP0595526A1 (en) 1994-05-04
EP0595526B1 (en) 1997-09-10
SG48753A1 (en) 1998-05-18
DE69313775T2 (de) 1998-01-22
ATE157874T1 (de) 1997-09-15
CA2108871A1 (en) 1994-04-24

Similar Documents

Publication Publication Date Title
FI914723A0 (fi) 17b-substituerade 4-aza-5a-androstan -3-jon-derivat och foerfarande foer framstaellning av desamma.
MX9201419A (es) Derivados de benzo isoxazol-piperidina.
ES2175336T3 (es) Derivados de triazol utiles en terapia.
ES2102154T3 (es) Inhibicion de trombina.
NZ325449A (en) Naphthyl-substituted benzimidazole derivatives as anticoagulants
PT1523298E (pt) Microemulsão contendo filtros de protecção de luz uv e/ou agentes anticaspa
DE69215345D1 (de) Behandlung von Synthesegas
NO932442D0 (no) Anvendelse av 1,3-oksatiolannukleosidanaloger ved behandling av hepatitt b
SE8503922L (sv) Analgetiska 1,2-bensisotiazol-3-ylpiperazin-derivat
DE3887614D1 (de) Substituierte Cycloalkanole.
ES2156120T3 (es) Derivados arilamidicos.
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
ES2181927T3 (es) Derivados de 1-metilcarbapenem.
DK0613687T3 (da) Anvendelse af pregnanderivat til behandling af tumorer
ES2108832T3 (es) Agente que mejora la circulacion periferica.
HUT71513A (en) 2-substituted-(3-chlorophenyl)-3,6-diazahexanoic acid derivatives for producing alkil-trazodone derivatives and process for producing them
ES2173466T3 (es) Derivados de anilinopeptido
FI840109A0 (fi) Foereningar foer behandling av hoegt blodtryck
NO976043D0 (no) Terapautiske forbindelser
NO962221L (no) Anvendelse av dimeticon for behandling av konstipasjon
EA199800085A1 (ru) Способ лечения боли висцерального происхождения, способ лечения воспалительного колита
ES2097435T3 (es) Derivados de 2,16-bispiperidinilandrostano monocuaternarios.
KR950019497U (ko) 보일러용 순환펌프의 본체
ES2116522T3 (es) Compuestos citotoxicos.
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 595526

Country of ref document: ES